<DOC>
	<DOCNO>NCT02716532</DOCNO>
	<brief_summary>This study target patient suffer acute brain injury ( ABI ) , include severe trauma brain injury ( sTBI ) aneurysmal sub arachnoid hemorrhage ( aSAH ) . This clinical study open-label , non-randomized , single-center , exploratory metabolic study . The primary objective determine change baseline ( enteral administration Peptamen AF ) plasma brain extracellular level MCFAs Ketone body sTBI patient upon Peptamen AF nutritional support .</brief_summary>
	<brief_title>Bioavailability Medium Chain Triglycerides ( MCTs ) Comatose Patients With Acute Brain Injury ( ABI )</brief_title>
	<detailed_description />
	<mesh_term>Wounds Injuries</mesh_term>
	<mesh_term>Brain Injuries</mesh_term>
	<mesh_term>Hemorrhage</mesh_term>
	<mesh_term>Subarachnoid Hemorrhage</mesh_term>
	<criteria>Comatose patient ( defined initial Glasgow Coma Scale ( GCS ) &lt; 9 ) follow sTBI aSAH . Female male , age &gt; 18 . Abnormal head CTScan ( contusion , hematoma ) . Intracranial monitoring CMD , [ PbtO2 ] [ ICP ] probe part standard care . Written inform consent independent physician ( associate research project ) provide medical followup defend patient 's interest . Written informed consent patient relative/legal representative confirming presumed patient willingness participate study Signs brain death expect brain death within 48h . Pregnancy . Hemodynamic instability ( circulatory shock , require vasopressor ) . Renal liver insufficiency . Chronic intestinal disease . Patients require parenteral nutrition . Currently participate participate another clinical trial month precede study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2016</verification_date>
</DOC>